Biweekly Progress Meeting (BPM) 6/27 Mon 09:00 Nanomaterials Group 7/4 Mon 08:30 Bio Group
Study Group Meeting (SGM) Tue 11:00 NMI / 16:30 MRB Wed 13:00 MG / 15:00 MNA Thu 12:00 SCSI / 15:00 TEM Fri 09:00 MBA / 10:30 N-TEC
Science Factory @Yonsei Season VII "Create Nano" Orientation
프로그램명: Science Factory @Yonsei 시즌 7 "Create Nano"
오리엔테이션 일정: 2022.7.4 (월) 14:00 ~ 18:00
IBS CNM's Campaign
A Sip of Inspiration
Advanced Healthcare Materials
“Magnetism-Optogenetic” System for Wireless and Highly Sensitive Neuromodulation
In this paper, a “magnetism-optogenetic” system is constructed, which uses a magnetic field to drive mechanoluminescent materials (ZnS:Cu) to generate light, thus stimulating photogenetic proteins. This system effectively combines the wireless magnetic regulation with the high sensitivity of optogenetics. The results show that the luminous intensity of this system changes with the power of an external ma-
gnetic field. In addition, under the continuous stimulation of the wireless magnetic field, this system can activate hippocampal-related neural responses and induce the expression of C-fos. In the end, this system can further regulate the movement behavior of rats with C1V1 protein expression in the primary motor cortex. This new magnetism-optogenetic system will provide an excellent reference for wireless and highly sensitive neuromodulation.
Characterization of nanoparticles-based vaccines for COVID-19
Several vaccines against COVID-19 use nanoparticles to protect the antigen cargo (either proteins or nucleic acids), increase the immunogenicity and ultimately the efficacy. The characterization of these nanomedicines is challenging due to their intrinsic complexity and requires the use of multidisciplinary techniques and competencies.
The accurate characterization of nanovaccines can be conceptualized as a combination of physicochemical, immunological and toxicological assays. This will help to address key challenges in the preclinical characterization, will guide the rapid development of safe and effective vaccines for current and future health crises, and will streamline the regulatory process.